Additionally, a 3D matrigel drop invasion assay revealed that overexpression of GPX4 significantly reversed the inhibitory effect of evodiamine on the invasion ability of prostate cancer cells (Fig. 5F). Here, GPX4 is linked to prostate carcinoma.